Exact Sciences Corporation
EXAS
$101.25
$0.050.05%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 14.47% | 12.56% | 11.57% | 10.37% | 11.91% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 14.47% | 12.56% | 11.57% | 10.37% | 11.91% |
| Cost of Revenue | 15.02% | 15.78% | 18.99% | 22.49% | 38.91% |
| Gross Profit | 14.21% | 11.06% | 8.32% | 5.29% | 2.34% |
| SG&A Expenses | 10.28% | 7.34% | 3.66% | 2.11% | 2.26% |
| Depreciation & Amortization | -3.21% | -54.95% | -209.91% | -- | -175.03% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 9.73% | 6.38% | 5.13% | 4.90% | 5.93% |
| Operating Income | 46.53% | 50.76% | 45.32% | 38.74% | 35.14% |
| Income Before Tax | -372.42% | -489.45% | -332.83% | -413.60% | 25.14% |
| Income Tax Expenses | -336.28% | -417.09% | -448.20% | -403.95% | 317.21% |
| Earnings from Continuing Operations | -360.94% | -474.39% | -324.54% | -403.97% | 24.13% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -360.94% | -474.39% | -324.54% | -403.97% | 24.13% |
| EBIT | 46.53% | 50.76% | 45.32% | 38.74% | 35.14% |
| EBITDA | 954.56% | 213.62% | 133.80% | 121.67% | 92.36% |
| EPS Basic | -353.69% | -464.23% | -315.26% | -390.03% | 25.81% |
| Normalized Basic EPS | 45.18% | 49.65% | 45.23% | 40.07% | 44.91% |
| EPS Diluted | -354.36% | -465.00% | -315.82% | -390.68% | 25.81% |
| Normalized Diluted EPS | 45.18% | 49.37% | 44.97% | 39.78% | 44.69% |
| Average Basic Shares Outstanding | 2.42% | 2.39% | 2.34% | 2.25% | 2.17% |
| Average Diluted Shares Outstanding | 2.42% | 1.91% | 1.85% | 1.77% | 1.68% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |